WEKO3
アイテム
Carbon Ion Therapy for Patients with Locally Recurrent Rectal Cancer
https://repo.qst.go.jp/records/65302
https://repo.qst.go.jp/records/653022a4f45f2-420f-48bc-9e4b-6159da2297c8
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2013-11-14 | |||||
タイトル | ||||||
タイトル | Carbon Ion Therapy for Patients with Locally Recurrent Rectal Cancer | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Yamada, Shigeru
× Yamada, Shigeru× Shinoto, Makoto× Yasuda, Shigeo× Imada, Hiroshi× Kamada, Tadashi× Tsujii, Hirohiko× Tsuji, Hiroshi× Baba, Masayuki× Mizoe, Junetsu× Yoshikawa, Kyosan× Kandatsu, Susumu× Ochiai, Takenori× 山田 滋× 篠藤 誠× 安田 茂雄× 今田 浩史× 鎌田 正× 辻井 博彦× 辻 比呂志× 馬場 雅行× 溝江 純悦× 吉川 京燦× 神立 進× 落合 武徳 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Purpose: To evaluate the tolerance for and effectiveness of carbon ion radiotherapy in patients with locally recurrent rectal cancer. Patients and Methods: We conducted a phase I/II dose escalation study of carbon ion radiotherapy . One hundred patients with 105 sites of locally recurrent cancer receiving carbon ion radiotherapy were analyzed. Forty-eight relapses originated in the presacral region, 28 in the pelvic sidewalls, 16 in the perineal region and 8 in the colorectal anastomosis. The total dose ranged from 67.2 to 73.6 gray equivalent (GyE) and was administered in 16 fixed fractions over 4 weeks (4.2to 4.6 GyE/fraction). Results: None of 75 patients treated with the highest total dose of 73.6 GyE experienced National Cancer Institute-Common Toxicity Criteria grade 3 to 5 acute reactions. The local control rate in patients treated with 73.6 GyE in the present study was 97% at one year and 92% at 3 years. Dose escalation was then halted at this leval. The median survival time in patients treated with 73.6 GyE was 54 months (range, 7 to 65 months), and the 1-and 3-year overall survival rates were 71% at 3 years and 39% at 5 years, respectively. Conclusion: Carbon ion radiotherapy seems to be a safe and effective modality in the management of locally recurrent rectal cancer, providing good local control and offering a survival advantage without unacceptable morbidity. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | II NIRS-CNAO Joint Symposium on Hadrontherapy | |||||
発表年月日 | ||||||
日付 | 2010-03-21 | |||||
日付タイプ | Issued |